Canada Contract Cell and Gene Therapy Manufacturing Market (2025-2031) | Trends, Analysis, Size, Share, Value, Forecast, Industry, Outlook, Companies, Growth, Segmentation & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Canada Country Macro Economic Indicators

3.2 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F

3.3 Canada Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle

3.4 Canada Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces

3.5 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F

3.6 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in cell and gene therapy research and development in Canada

4.2.2 Favorable government regulations and policies supporting the growth of the contract cell and gene therapy manufacturing market

4.2.3 Growing demand for personalized medicine and advanced therapies driving the need for contract manufacturing services

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy manufacturing processes

4.3.2 Limited availability of skilled workforce specialized in cell and gene therapy manufacturing in Canada

4.3.3 Stringent regulatory requirements and challenges in obtaining approvals for cell and gene therapy products

6.1 Canada Contract Cell and Gene Therapy Manufacturing Market, By Vector

6.1.1 Overview and Analysis

6.1.2 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2021-2031F

6.1.3 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2021-2031F

6.2 Canada Contract Cell and Gene Therapy Manufacturing Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2021-2031F

6.2.3 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2021-2031F

6.2.4 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Herpetological Diseases, 2021-2031F

6.2.5 Canada Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021-2031F

7.1 Canada Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries

7.2 Canada Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries

8.1 Capacity utilization rate of contract cell and gene therapy manufacturing facilities in Canada

8.2 Number of new partnerships and collaborations established between contract manufacturers and biopharmaceutical companies in the cell and gene therapy sector

8.3 Rate of adoption of advanced manufacturing technologies and automation in cell and gene therapy manufacturing processes

9.1 Canada Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F

9.2 Canada Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 Canada Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024

10.2 Canada Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters